Drug Type Biological products |
Synonyms- |
Target |
Mechanism WEE1 inhibitors(Serine/threonine-protein kinase WEE1 inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | US | 01 Jan 2021 |